Today on in-pharmatechnologist.com   Novartis launches initiative with 2,500 job losses West Pharma unit to suffer in post-Exubera fallout Novozymes and Millipore to supply cell culture supplements Pharmaceutical patent round-up NNE wins Pronova contract

Related Industry News   Biogen Idec shares nosedive after withdrawing 'for sale' sign Biomarker detection gets 'sticky' New cell line to tackle drug resistant cancer Mini synchrotron to ease structural analysis?

		In association with
Breaking News on Pharmaceutical Technology
Daily  Thursday 13 December 2007		Forward to a colleague

	Seminar Info Premier event for excipient manufacturers and end-users Europe's only dedicated forum on issues affecting the excipients sector is just two months away. Don't miss your chance to hear the latest on key topics such as supply chain integrity, counterfeiting, excipient master files and REACH... Click Here Access Full Stories Novartis launches initiative with 2,500 job losses Novartis is to sever a further 2,500 jobs as part of a new initiative aimed to 'improve competitiveness in a dynamically changing healthcare environment'... Read West Pharma unit to suffer in post-Exubera fallout The repercussions of Pfizer's dramatic Exubera exit are finally filtering through to West Pharmaceutical Services, with the company preparing to restructure its affected Tech Group contract manufacturing unit... Read Novozymes and Millipore to supply cell culture supplements Novozymes and Millipore are to supply animal-free cell culture supplements to the biopharmaceutical industry... Read Pharmaceutical patent round-up In-PharmaTechnologist.com brings you an update of pharmaceutical patent litigations... Read NNE wins Pronova contract NNE Pharmaplan has won a contract with Pronova BioPharma to build the company's new pharma production facility in Kalundborg, Denmark... Read
	All News Headlines for: December | November | October
	Product Brochure Maximum flexibility and high speed with the new MCPV850. Presenting the first Marchesini case packer & palletiser to have a vertical case packer, combining in a single compact block the two operations consisting of vertical case packing and palletizing... Click Here
	Advertisement Related Industry News Biogen Idec shares nosedive after withdrawing 'for sale' sign Like countless pets after every Christmas, it seems that nobody wanted Biogen Idec after all; the firm has announced it will remain independent after it 'did not receive any definitive offers to purchase the company'... Read Biomarker detection gets 'sticky' US researchers have developed a fast and inexpensive protein biomarker detection device that could simplify disease diagnosis and aid in following disease progression in drug trials... Read New cell line to tackle drug resistant cancer The creation of a new 'super cell' that can stand firm against one of the newest types of cancer therapy could shed new light on how to treat patients if they become resistant to these drugs... Read Mini synchrotron to ease structural analysis? Researchers have developed a miniature synchrotron that could enable researchers to conduct protein crystallography experiments in their own university and 'revolutionise the way science is done'... Read Weekly Comment Paediatric drugs and testing highlighted The importance of paediatric drug formulations and clinical trials in children was highlighted at this month's American Association of Pharmaceutical Scientists (AAPS) conference in San Diego. Read Application Note Transdermal Sufentanil Licensing Opportunity Aveva's 7-day sufentanil's advanced technology and patient benefits will enable Aveva and its Partner to capture a significant share of the existing $3.9 billion dollar chronic pain market... Click Here Previous Headlines Pharmaceutical manufacturing: people on the move Vyteris, Sciele Pharma, Nektar Therapeutics, Fundamental Applied Biology and Artes Medical have all had people on the move in the world of pharmaceutical manufacturing... Read BioWa and Lonza agreement for potent antibodies BioWa and Lonza are joining forces to develop a new technology platform to produce more potent antibodies with enhanced cell-killing powers... Read Hikma still in 'acquisition mode' on APM buy Hikma has ticked another pharma firm off its shopping list as it acquires the Arab Pharmaceutical Manufacturing Company (APM) for $163.6m... Read Eli Lilly signals vigour for outsourcing Eli Lilly is the latest big pharma company to signal plans of a vigorous commitment to outsourcing in a bid to prevent its fortunes fading... Read GE Healthcare and Novavax collaborate on pandemic flu solution GE Healthcare and Novavax have a vision - a state-of-the-art pandemic influenza vaccine manufacturing facility solution with the ability to produce vaccines quickly, which can be marketed as a product to international... Read Technical / White Papers, Case studies, Web casts Shop floor integration at Novartis Singapore - Case Study Sensitive and selective with IC-MS coupling - Technical / White Paper Product Information - brochures, Web centers Transdermal Sufentanil Licensing Opportunity - Application Notes Reproducible, homogeneous dry dispersions by the Morphologi® - Application Notes A Review of Dissolution tests with the Flow Through Method - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Cleanroom, safety equipment, supplies Contract services (outsourcing) Drug delivery systems Ingredients, excipients and raw materials IT solutions Lab equipment & consumables Packaging machinery & supplies Processing (automation, control, separation...) QA/QC & validation Tabletting, coating & ancillary equipment

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@In-PharmaTechnologist.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com